Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lactate dehydrogenase C4 (LDHC) is a unique isoenzyme of lactate dehydrogenase primarily expressed in mammalian testis and spermatozoa. It plays a critical role in energy metabolism, particularly in sperm function and male fertility, and has recently gained attention as a cancer-testis antigen (CTA) due to its aberrant expression in various cancers. Targeting/inhibiting *LDHC* sensitizes some tumors to DNA damage response therapies; ongoing research explores its value both diagnostically & therapeutically.
LDHC inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactate dehydrogenase C4 (LDHC).